BEKSAÇ, M. Et Al. 2019. A retrospective single center experience with the generic of lenalidomide Rivelime (R) compared with original patented drug Revlimid (R). Lymphoma and Myeloma Congress 2019 .

BEKSAÇ, M., CENGİZ SEVAL, G., KOYUN, D., TOPÇUOĞLU, P., YÜKSEL, M., GÜRMAN, G., ... İLHAN, O.(2019). A retrospective single center experience with the generic of lenalidomide Rivelime (R) compared with original patented drug Revlimid (R) . Lymphoma and Myeloma Congress 2019

BEKSAÇ, MERAL Et Al. "A retrospective single center experience with the generic of lenalidomide Rivelime (R) compared with original patented drug Revlimid (R)," Lymphoma and Myeloma Congress 2019, 2019

BEKSAÇ, MERAL Et Al. "A retrospective single center experience with the generic of lenalidomide Rivelime (R) compared with original patented drug Revlimid (R)." Lymphoma and Myeloma Congress 2019 , 2019

BEKSAÇ, M. Et Al. (2019) . "A retrospective single center experience with the generic of lenalidomide Rivelime (R) compared with original patented drug Revlimid (R)." Lymphoma and Myeloma Congress 2019 .

@conferencepaper{conferencepaper, author={MERAL BEKSAÇ Et Al. }, title={A retrospective single center experience with the generic of lenalidomide Rivelime (R) compared with original patented drug Revlimid (R)}, congress name={Lymphoma and Myeloma Congress 2019}, city={}, country={}, year={2019}}